About Xhale
Xhale is a Healthcare company based in Gainesville (United States) founded in 2005, and was acquired by Philips in August 2018. It develops exhaled breath and novel vapor analysis technology used for medication adherence among other things. It operates in the Healthcare and Technology sectors. Xhale has raised $21.22 million across 5 funding rounds from investors including Philips and HHS. The company has 8 employees. The company was acqui-hired. Its focus areas include HealthTech, Healthcare IT, Value Based Care and Remote Monitoring. Its competitors include Endotronix, Edwards Lifesciences and CoachCare; 2 of its 3 listed competitors have raised funding.
Company details
Xhale was founded in 2005 in Gainesville, United States, within the medtech sector. Exhaled breath and vapor analysis technologies are developed for applications including medication adherence. Self-Monitoring And Reporting Therapeutics (SMART) technology is provided to enable breath-detectable versions of pharmaceuticals. Clinical trial monitoring systems are offered to verify participant compliance with dosing. Drug metabolism assessment tools are also supplied for point-of-care use by physicians and hospitals.
Funding Insights of Xhale
Xhale has successfully raised a total of $21.22M across 5 strategic funding rounds. The most recent funding activity was a Series C round of $4.55 million completed in July 2014. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $21.22M
- Total Rounds 5
- Last Round Series C — $4.55M
- First Round $1.71M
(Aug 2009)
- Investors Count 1
All 5 funding rounds of Xhale with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
2 investors in total: 2 institutional.
Investors in Xhale
Xhale has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include Philips and HHS.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Public health and human services are overseen by HHS. | 1953 | hhs.gov | ||
Diversified products are provided across health, lighting, and consumer sectors. | 1891 | philips.com | Amsterdam, Netherlands |
Investor details for Xhale
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Xhale
4 dated milestones of Xhale across 13 years, from founding to its latest funding, stage changes and deals.
- Founded Xhale is founded.
- Funding First funding round of $1.7M.
- Funding Latest funding round, Series C, of $4.6M.
- Exit Acquired by Philips.
Competitors of Xhale
Xhale has 3 listed competitors in our database, 2 of them funded. They include Endotronix, Edwards Lifesciences and CoachCare.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| endotronix.com | 2007 | East Peoria, United States | $154.77M | 104 | Miniaturized wireless implantable sensors are developed for hemodynamic monitoring. | |
| edwards.com | 1958 | Irvine, United States | 19,800 | Medical devices for structural heart disease are developed and provided. | ||
| coachcare.com | 2013 | New York, United States | $60.2M | Remote monitoring platform for tracking patient activity |
Detailed competitors of Xhale
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Clinical IT & Data Platforms
3 companies that operate in the same segment as Xhale (Clinical IT & Data Platforms) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Employee health benefits are facilitated via a cloud-based platform. | 2007 | Plymouth Meeting, Pennsylvania, United States | USD 228.3 M | |||
Healthcare appointments are booked online via Zocdoc's platform. | 2007 | New York, New York, United States | USD 425.97 M | USD 4.66 M | 1,365 | |
Virtual physical therapy and digital pain care solutions are provided. | 2015 | San Francisco, California, United States | USD 854.44 M | 1,746 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Xhale
Complete news archive for Xhale
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Xhale
Xhale was founded in 2005 and raised its 1st funding round 4 years after it was founded.
Xhale is headquartered in Gainesville, United States.
Xhale is a funded company, having raised a total of $21.22M across 5 funding rounds to date. The company's 1st funding round was a Grant of $1.71M, raised on Aug 2009.
Xhale has 8 employees.
Xhale was founded in 2005 in Gainesville, United States, within the medtech sector. Exhaled breath and vapor analysis technologies are developed for applications including medication adherence. Self-Monitoring And Reporting Therapeutics (SMART) technology is provided to enable breath-detectable versions of pharmaceuticals. Clinical trial monitoring systems are offered to verify participant compliance with dosing. Drug metabolism assessment tools are also supplied for point-of-care use by physicians and hospitals.
Xhale's top competitors include Endotronix, CoachCare and Edwards Lifesciences.
Yes. Xhale was acquired by Philips in August 2018.